Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients

NCT01590979 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT01590979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients
Lead sponsor
Northwell Health
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2012
Completion date
June 30, 2015
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation new onset, hemorrhage, medical care; complications, late effect of complications, prolonged qtc interval, ventricular tachycardia